Li Hai, male, doctor of medicine, chief physician, professor and master tutor of the Armed Police Logistics College and Tianjin University of Traditional Chinese Medicine.
He is currently the director of the Department of Gastroenterology and the director of the Department of Infectious Diseases at Tianjin Xiqing Hospital.
He is currently serving as a youth member of the Chinese Medical Association Hepatology Branch, a member of the Fatty Liver and Alcoholic Liver Study Group, a member of the Liver Fibrosis, Cirrhosis and Portal Hypertension Study Group; the deputy director of the Tianjin Medical Association Liver Disease Branch, and the fluid therapy of the Tianjin Medical Association Member of the Standing Committee of the Credit Society, Chairman of the Tianjin Alliance of the Asia-Pacific Liver Disease Alliance, National Executive Director of the Asia-Pacific Liver Disease Alliance, Secretary-General of the Tasly Fatty Liver College of the Chinese Medical Doctor Association, Member of the Digestive Disease Branch of the Tianjin Medical Doctor Association, and the Digestive Disease Branch of the Tianjin Society of Integrative Traditional Chinese and Western Medicine Member, national committee member of the National Cooperative Group for Difficult and Severe Liver Disease Research and other academic positions.
He is currently the deputy editor-in-chief of the Chinese Journal of Hepatology, editorial board member or reviewer of Chinese Journal of Hepatology, Chinese Journal of Virology, and Journal of Clinical Hepatobiliary Diseases.
Editor-in-Chief and Deputy Editor-in-Chief (Translation) of 8 professional books, participated in the editing of many books
Representative works are:
Editor-in-chief of “Guidelines and Clinical Practice of Liver Diseases” Science Press in 2018;
“Core Knowledge of Gastrointestinal and Hepatic Diseases” Science Press 2019 Chief translator;
Deputy editor-in-chief of “Infectious Diseases” People’s Health Publishing House in 2012;
“The Relationship Between Liver Fibrosis and Hepatocellular Carcinoma” in the first section of “Molecular aspects of hepatocellular carcinoma”; etc.
Published more than 70 papers, the main research direction is fatty liver and liver fibrosis immune pathogenesis and clinical research. He has presided over a number of scientific research projects at various levels, including the person in charge of two major sub-centers of the 13th Five-Year Plan, one of the sub-centers of the National Major Special Projects, and two participating in the National Natural Science Foundation of China.
In 2003, he was awarded the advanced individual in fighting against SARS in Tianjin, in 2003, he was awarded the Excellent Communist Party Member of Tianjin Municipal Health Bureau, in 2005, he was awarded the Tianjin New Long March Assault Soldier, and in 2015, he was awarded the third-class merit medal of the Chinese People’s Liberation Army. In 2021, the fever clinic of Tianjin Xiqing Hospital under his leadership won the “Model Group” in Tianjin, and won the titles of “Top Ten Doctors” and “Advanced Medical Workers” many times.